Literature DB >> 30029007

Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module.

Haibin Wang1, Wen-Ting Lo1, Andreja Vujičić Žagar2, Federico Gulluni3, Martin Lehmann1, Leonardo Scapozza2, Volker Haucke4, Oscar Vadas5.   

Abstract

Class II phosphoinositide 3-kinases (PI3K-C2) are large multidomain enzymes that control cellular functions ranging from membrane dynamics to cell signaling via synthesis of 3'-phosphorylated phosphoinositides. Activity of the alpha isoform (PI3K-C2α) is associated with endocytosis, angiogenesis, and glucose metabolism. How PI3K-C2α activity is controlled at sites of endocytosis remains largely enigmatic. Here we show that the lipid-binding PX-C2 module unique to class II PI3Ks autoinhibits kinase activity in solution but is essential for full enzymatic activity at PtdIns(4,5)P2-rich membranes. Using HDX-MS, we show that the PX-C2 module folds back onto the kinase domain, inhibiting its basal activity. Destabilization of this intramolecular contact increases PI3K-C2α activity in vitro and in cells, leading to accumulation of its lipid product, increased recruitment of the endocytic effector SNX9, and facilitated endocytosis. Our studies uncover a regulatory mechanism in which coincident binding of phosphoinositide substrate and cofactor selectively activate PI3K-C2α at sites of endocytosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  clathrin; endocytosis; hydrogen-deuterium exchange mass spectrometry; lipid-binding domain; phosphatidylinositol 3,4-bisphosphate; phosphatidylinositol 3-kinase C2alpha; phosphoinositides; sorting nexin

Mesh:

Substances:

Year:  2018        PMID: 30029007     DOI: 10.1016/j.molcel.2018.06.042

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  16 in total

1.  An Overview of Class II Phosphoinositide 3-Kinases.

Authors:  Emily Yan Zhi Heng; Tania Maffucci
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

2.  Development of selective inhibitors of phosphatidylinositol 3-kinase C2α.

Authors:  Wen-Ting Lo; Hassane Belabed; Murat Kücükdisli; Juliane Metag; Yvette Roske; Polina Prokofeva; Yohei Ohashi; André Horatscheck; Davide Cirillo; Michael Krauss; Christopher Schmied; Martin Neuenschwander; Jens Peter von Kries; Guillaume Médard; Bernhard Kuster; Olga Perisic; Roger L Williams; Oliver Daumke; Bernard Payrastre; Sonia Severin; Marc Nazaré; Volker Haucke
Journal:  Nat Chem Biol       Date:  2022-09-15       Impact factor: 16.174

3.  PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation.

Authors:  Federico Gulluni; Lorenzo Prever; Huayi Li; Petra Krafcikova; Ilaria Corrado; Wen-Ting Lo; Jean Piero Margaria; Anlu Chen; Maria Chiara De Santis; Sophie J Cnudde; Joseph Fogerty; Alex Yuan; Alberto Massarotti; Nasrin Torabi Sarijalo; Oscar Vadas; Roger L Williams; Marcus Thelen; David R Powell; Markus Schueler; Michael S Wiesener; Tamas Balla; Hagit N Baris; Dov Tiosano; Brian M McDermott; Brian D Perkins; Alessandra Ghigo; Miriam Martini; Volker Haucke; Evzen Boura; Giorgio Roberto Merlo; David A Buchner; Emilio Hirsch
Journal:  Science       Date:  2021-12-10       Impact factor: 63.714

4.  Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway.

Authors:  Haibin Wang; Dinah Loerke; Caroline Bruns; Rainer Müller; Philipp-Alexander Koch; Dmytro Puchkov; Carsten Schultz; Volker Haucke
Journal:  J Biol Chem       Date:  2019-12-12       Impact factor: 5.157

5.  The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells.

Authors:  Khin Thuzar Aung; Kazuaki Yoshioka; Sho Aki; Kazuhiro Ishimaru; Noriko Takuwa; Yoh Takuwa
Journal:  J Physiol Sci       Date:  2018-10-29       Impact factor: 2.781

Review 6.  Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking.

Authors:  Kazuaki Yoshioka
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

Review 7.  Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K.

Authors:  Ivan Yudushkin
Journal:  Biomolecules       Date:  2019-02-16

8.  TGFβ receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2α-, and INPP4B-mediated phosphoinositide conversions.

Authors:  Sho Aki; Kazuaki Yoshioka; Noriko Takuwa; Yoh Takuwa
Journal:  Mol Biol Cell       Date:  2020-01-08       Impact factor: 4.138

Review 9.  PI3K inhibitors in thrombosis and cardiovascular disease.

Authors:  Tom N Durrant; Ingeborg Hers
Journal:  Clin Transl Med       Date:  2020-01-31

10.  Structural insights into an atypical secretory pathway kinase crucial for Toxoplasma gondii invasion.

Authors:  Gaëlle Lentini; Rouaa Ben Chaabene; Oscar Vadas; Chandra Ramakrishnan; Budhaditya Mukherjee; Ved Mehta; Matteo Lunghi; Jonas Grossmann; Bohumil Maco; Rémy Visentin; Adrian B Hehl; Volodymyr M Korkhov; Dominique Soldati-Favre
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.